206 related articles for article (PubMed ID: 38502259)
21. Molecular Profiling of Salivary Oncocytic Mucoepidermoid Carcinomas Helps to Resolve Differential Diagnostic Dilemma With Low-grade Oncocytic Lesions.
Skálová A; Agaimy A; Stanowska O; Baneckova M; Ptáková N; Ardighieri L; Nicolai P; Lombardi D; Durzynska M; Corcione L; Laco J; Koshyk O; Žalud R; Michal M; Vanecek T; Leivo I
Am J Surg Pathol; 2020 Dec; 44(12):1612-1622. PubMed ID: 33002921
[TBL] [Abstract][Full Text] [Related]
22. A minority of cases of acinic cell carcinoma of the salivary glands are driven by an NR4A2 rearrangement: the diagnostic utility of the assessment of NR4A2 and NR4A3 alterations in salivary gland tumors.
Klubíčková N; Grossmann P; Šteiner P; Baněčková M; Mosaieby E; Koshyk O; Michal M; Leivo I; Skálová A
Virchows Arch; 2023 Feb; 482(2):339-345. PubMed ID: 36469101
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological study of intraductal carcinoma of the salivary gland, with emphasis on the apocrine type.
Hsieh MS; Lee YH; Jin YT; Kuo YJ
Virchows Arch; 2020 Oct; 477(4):581-592. PubMed ID: 32383006
[TBL] [Abstract][Full Text] [Related]
24. NOR-1 (NR4A3) immunostaining on cytologic preparations for the preoperative diagnosis of acinic cell carcinoma of the salivary gland.
Krishnan V; Nguyen L; Shen R; Lieu D; De Peralta-Venturina M; Fan X
J Am Soc Cytopathol; 2022; 11(6):352-358. PubMed ID: 36058827
[TBL] [Abstract][Full Text] [Related]
25. Utility of an immunocytochemical analysis for pan-Trk in the cytodiagnosis of secretory carcinoma of the salivary gland.
Ito H; Ishida M; Ebisu Y; Okano K; Sandoh K; Noda Y; Miyasaka C; Fujisawa T; Yagi M; Iwai H; Tsuta K
Diagn Cytopathol; 2021 Aug; 49(8):E329-E335. PubMed ID: 33885200
[TBL] [Abstract][Full Text] [Related]
26. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
[TBL] [Abstract][Full Text] [Related]
27. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland.
Bell D; Ferrarotto R; Liang L; Goepfert RP; Li J; Ning J; Broaddus R; Weber RS; El-Naggar AK
Virchows Arch; 2020 Feb; 476(2):295-305. PubMed ID: 31423558
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.
Hung YP; Jo VY; Hornick JL
Histopathology; 2019 Jul; 75(1):54-62. PubMed ID: 30801752
[TBL] [Abstract][Full Text] [Related]
29. Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands.
Haller F; Skálová A; Ihrler S; Märkl B; Bieg M; Moskalev EA; Erber R; Blank S; Winkelmann C; Hebele S; Baněčková M; Wiemann S; Müller S; Zenk J; Eils R; Iro H; Hartmann A; Agaimy A
Am J Surg Pathol; 2019 Sep; 43(9):1264-1272. PubMed ID: 31094928
[TBL] [Abstract][Full Text] [Related]
30. Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics.
Pinto A; Nosé V; Rojas C; Fan YS; Gomez-Fernandez C
Mod Pathol; 2014 Jan; 27(1):30-7. PubMed ID: 23807775
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic pitfalls of aspiration cytology of salivary duct carcinoma.
Khurana KK; Pitman MB; Powers CN; Korourian S; Bardales RH; Stanley MW
Cancer; 1997 Dec; 81(6):373-8. PubMed ID: 9438463
[TBL] [Abstract][Full Text] [Related]
32. PON3::LCN1 and HTN3::MSANTD3 Gene Fusions With NR4A3/NR4A2 Expression in Salivary Acinic Cell Carcinoma.
Zhu L; Sun L; Zhang Y; Liu X; Li X; Zhou Z; Cui Y; Zhou CX; Li TJ
Am J Surg Pathol; 2024 Jun; 48(6):681-690. PubMed ID: 38682454
[TBL] [Abstract][Full Text] [Related]
33. Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature.
Fan CY; Wang J; Barnes EL
Am J Surg Pathol; 2000 Apr; 24(4):579-86. PubMed ID: 10757407
[TBL] [Abstract][Full Text] [Related]
34. Mist1: a novel nuclear marker for acinic cell carcinoma of the salivary gland.
Hsieh MS; Jeng YM; Lee YH
Virchows Arch; 2019 Nov; 475(5):617-624. PubMed ID: 31187185
[TBL] [Abstract][Full Text] [Related]
35. MUC4 is a valuable marker for distinguishing secretory carcinoma of the salivary glands from its mimics.
Taverna C; Baněčková M; Lorenzon M; Palomba A; Franchi A; Skalova A; Agaimy A
Histopathology; 2021 Sep; 79(3):315-324. PubMed ID: 32931030
[TBL] [Abstract][Full Text] [Related]
36. Utility of MUC4 in the diagnosis of secretory carcinoma of salivary glands.
Fatima S; Ahmed A; Suleman S; Din NU
Ann Diagn Pathol; 2023 Dec; 67():152220. PubMed ID: 37924657
[TBL] [Abstract][Full Text] [Related]
37. Androgen receptor immunohistochemistry in salivary duct carcinoma: a retrospective study of 188 cases focusing on tumoral heterogeneity and temporal concordance.
Xu B; Dogan S; Haroon Al Rasheed MR; Ghossein R; Katabi N
Hum Pathol; 2019 Nov; 93():30-36. PubMed ID: 31430492
[TBL] [Abstract][Full Text] [Related]
38. Salivary Duct Carcinoma: An Update on Morphologic Mimics and Diagnostic Use of Androgen Receptor Immunohistochemistry.
Udager AM; Chiosea SI
Head Neck Pathol; 2017 Sep; 11(3):288-294. PubMed ID: 28321773
[TBL] [Abstract][Full Text] [Related]
39. Frankly Invasive Carcinoma Ex-intraductal Carcinoma: Expanding on an Emerging and Perplexing Concept in Salivary Gland Tumor Pathology.
McLean-Holden AC; Rooper LM; Lubin DJ; Magliocca KR; Manucha V; Sadow PM; Tobias J; Vargo RJ; Thompson LDR; Heidarian A; Weinreb I; Wenig B; Gagan J; Hernandez-Prera JC; Bishop JA
Head Neck Pathol; 2022 Sep; 16(3):657-669. PubMed ID: 34985683
[TBL] [Abstract][Full Text] [Related]
40. GATA3 immunohistochemical expression in salivary gland neoplasms.
Schwartz LE; Begum S; Westra WH; Bishop JA
Head Neck Pathol; 2013 Dec; 7(4):311-5. PubMed ID: 23604756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
